)
)
)
Roundtable: China - Understanding the Interaction Between RDP, PTE and Patent Linkage Frameworks
China’s dynamic IP and regulatory landscape presents a distinct set of risks and opportunities for pharmaceutical innovators, biosimilar companies and generic drug manufacturers alike. This discussion focuses on China’s recently introduced Regulatory Data Protection (RDP) framework and examines how the new regime will interact with established Patent Term Extension and patent linkage systems.